Design (Testphase)
Risk & Weakness
Stan Weinstein: Stage 4
418
Findings
July 21, 2026
last calculated
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · showing the 25 strongest hits
Weinstein Stage 4 — downtrend: the price sits below the falling 30-week line, with lower highs and lower lows. Avoid on the long side; more likely short candidates.
Global filters: 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); fundamentally healthy names (Piotroski ≥ 5 or Funda Rating ≥ +10) are excluded.
🔔 Watch scanner
Terms in This Scanner Explained
(16)
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth Minnow Street company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from -100 to +100 with a school-grade rank from A+ to F. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. A/A+ are the fundamentally strongest stocks in the universe.
- Long / Short
- Long = betting on rising prices (buying the stock). Short = betting on falling prices (selling borrowed shares to buy them back cheaper later). Our short scanners are warning or watch lists - not buy candidates.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CRML Critical Metals Corp. Ordinary Sha | — | -20 % | 50 5/23 | Stage 4 | D -35 | 2 of 9 | 1.5 | Other Industrial Metals & Mi | – | — | — | Basic Materials | 6.20 $ | +39.9 % | +24.3 % | +286.4 % | −71.2 % | +83.6 % | 91 | 42 | 7.8 % | 8.3 % | 1.86 | — | 0.0 | — | 9.5 | — | — | 0.0 | — | 100.0 % | 0.0 % | -141.0 % | -15.7 % | 0.00 | — | +376.5 % | 0.0 % | 0.0 % | -0.8 | 15.9 % | 28.9 % | — |
| REAL TheRealReal Inc | 08/06 | +260 % | 21 4/31 | Stage 4 | C +8 | 3 of 9 | 1.5 | Luxury Goods | Uses AI | — | Consumer Cyclical | 11.50 $ | -22.6 % | -24.8 % | +162.5 % | −28.5 % | +38.8 % | 79 | 42 | 7.3 % | 6.4 % | 2.67 | — | 178.6 | 2.1 | 4.8 | 120.4 | — | 93.7 | -1.2 % | 74.5 % | -9.0 % | -932.7 % | -2.2 % | -1.29 | -93.1 % | +15.4 % | 0.0 % | 0.0 % | -9.2 | 98.4 % | 16.7 % | 1.7 (7) | |
| UAMY United States Antimony Corporation | 08/11 | +720 % | — | Stage 4 | D -24 | 1 of 9 | 0.0 | Other Industrial Metals & Mining | – | — | — | Basic Materials | 5.40 $ | +39.6 % | +9.6 % | +141.5 % | −65.2 % | +83.1 % | 78 | 50 | 8.1 % | 8.7 % | 0.35 | — | 78.1 | — | 7.7 | — | — | 14.7 | — | 22.1 % | -41.4 % | -19.7 % | -11.2 % | 0.00 | — | +162.8 % | 0.0 % | 0.0 % | 11.2 | 57.4 % | 22.0 % | — |
| IMDX Insight Molecular Diagnostics Inc. | 08/10 | +11 % | 57 5/22 | Stage 4 | D -26 | 2 of 9 | 0.2 | Diagnostics & Research | Neutral | — | — | Healthcare | 4.80 $ | -28.4 % | -6.9 % | +47.0 % | −34.3 % | +49.1 % | 74 | 42 | 8.9 % | 10.6 % | 1.77 | — | 0.0 | 93.2 | 87.1 | — | — | -1.3 | — | 51.1 % | 0.0 % | -23,603.1 % | -43.4 % | -0.29 | — | +115.6 % | 0.0 % | 0.0 % | -34.6 | 61.4 % | 7.2 % | — |
| SGHT Sight Sciences Inc | 08/06 | -10 % | 7 1/22 | Stage 4 | D -24 | 4 of 9 | 0.3 | Medical Devices | – | — | — | Healthcare | 5.00 $ | -31.8 % | -35.5 % | +26.7 % | −40.9 % | +56.4 % | 73 | 42 | 6.8 % | 6.6 % | 2.38 | — | 0.0 | 3.7 | — | — | — | -4.2 | — | 86.2 % | -46.8 % | -56.6 % | -14.3 % | — | — | -3.1 % | 0.0 % | 0.0 % | -4.2 | 54.0 % | 2.0 % | — |
| INDI indie Semiconductor Inc | 08/06 | -20 % | 46 5/25 | Stage 4 | D -26 | 2 of 9 | 0.8 | Semiconductors | – | — | — | Technology | 3.80 $ | +5.1 % | +0.0 % | +14.1 % | −39.0 % | +58.4 % | 64 | 42 | 8.0 % | 9.0 % | 2.74 | — | 128.2 | 3.8 | 2.3 | — | — | -10.5 | — | -29.9 % | -69.4 % | -41.2 % | -10.2 % | 1.33 | — | +0.3 % | 0.0 % | 0.0 % | 2.1 | 109.0 % | 30.6 % | — |
| ZBIO Zenas BioPharma, Inc. Common Stock | 08/11 | — | 81 7/22 | Stage 4 | D -19 | 2 of 9 | 1.6 | Biotechnology | – | — | — | Healthcare | 30.70 $ | -44.4 % | -40.8 % | +130.2 % | −44.7 % | +70.8 % | 57 | 42 | 8.2 % | 7.6 % | — | — | 0.0 | 160.0 | — | — | — | 0.0 | — | — | 0.0 % | -137.1 % | -29.1 % | — | — | +100.0 % | 0.0 % | 0.0 % | 2.6 | 90.5 % | 26.3 % | — |
| W Wayfair Inc | 08/03 | +16 % | 8 2/31 | Stage 4 | D -17 | 3 of 9 | 12.4 | Internet Retail | – | — | — | Consumer Cyclical | 87.80 $ | -15.5 % | -5.0 % | +89.9 % | −22.1 % | +0.0 % | 56 | 13 | 6.5 % | 6.8 % | 2.96 | — | 34.2 | 1.0 | 2,679.5 | 27.1 | 23.50 | 117.6 | 0.4 % | 30.4 % | -2.4 % | 0.0 % | 3.7 % | -1.28 | -99.0 % | +5.1 % | 0.0 % | 0.0 % | -4.4 | 113.3 % | 19.3 % | 1.5 (35) |
| NB NioCorp Developments Ltd. Common S | 07/10 | -1 % | 37 4/23 | Stage 4 | D -11 | 4 of 9 | 0.7 | Other Industrial Metals & Mi | – | — | — | Basic Materials | 4.30 $ | -7.4 % | -25.1 % | +62.7 % | −63.4 % | +154.3 % | 55 | 42 | 5.6 % | 7.2 % | 0.17 | — | 0.0 | — | 1.5 | — | — | -3.3 | — | — | 0.0 % | -24.5 % | -8.7 % | 0.00 | — | -8.0 % | 0.0 % | 0.0 % | 20.0 | 38.1 % | 5.7 % | — |
| IRON Disc Medicine Inc. | 08/06 | +11 % | 28 3/22 | Stage 4 | D -37 | 2 of 9 | 2.7 | Biotechnology | – | — | — | Healthcare | 74.40 $ | -11.3 % | -7.4 % | +36.2 % | −29.5 % | +44.7 % | 54 | 42 | 4.3 % | 4.6 % | 2.07 | — | 0.0 | — | 4.2 | — | — | -7.6 | 0.0 % | — | 0.0 % | -35.8 % | -22.7 % | 0.05 | 91.8 % | — | 0.0 % | 0.0 % | 16.6 | 113.7 % | 18.4 % | 1.0 (11) |
| AMRC Ameresco Inc | 08/03 | -14 % | 49 6/29 | Stage 4 | C +9 | 3 of 9 | 1.5 | Engineering & Construction | – | — | — | Industrials | 22.60 $ | -5.2 % | -12.4 % | +92.6 % | −38.2 % | +54.5 % | 54 | 14 | 5.6 % | 7.2 % | 2.60 | 46.2 | 23.5 | 0.7 | 1.3 | — | 2.14 | 13.8 | — | 15.6 % | 1.6 % | 4.4 % | 1.7 % | 1.85 | — | +9.2 % | 0.0 % | 0.0 % | 5.0 | 99.3 % | 14.9 % | — |
| MNKD MannKind Corp | 08/05 | +0 % | 69 6/22 | Stage 4 | D -23 | 2 of 9 | 1.2 | Biotechnology | – | — | — | Healthcare | 4.00 $ | -30.7 % | -28.5 % | +1.1 % | −39.6 % | +93.2 % | 53 | 19 | 5.3 % | 5.9 % | 1.09 | — | 47.6 | 3.3 | 187.9 | 94.5 | 4.39 | 57.9 | -3.3 % | 75.6 % | -6.6 % | 0.0 % | 2.0 % | -7.38 | -8.0 % | +22.2 % | 0.0 % | 0.0 % | -9.8 | 59.3 % | 10.3 % | 1.0 (7) |
| BLD Topbuild Corp | 08/04 | +21 % | 23 4/29 | Stage 4 | C +3 | 4 of 9 | 12.2 | Engineering & Construction | – | — | — | Industrials | 427.10 $ | -2.3 % | -16.0 % | +28.1 % | −23.7 % | +9.2 % | 50 | 26 | 4.3 % | 3.2 % | 1.83 | 24.0 | 19.6 | 2.2 | 5.0 | 17.3 | — | 12.9 | 12.2 % | 29.0 % | 9.0 % | 22.3 % | 9.2 % | 1.30 | 35.8 % | +1.5 % | 0.0 % | 0.0 % | 7.3 | 105.1 % | 12.5 % | 1.3 (12) |
| BOOM Dmc Global Inc | 08/04 | -20 % | 60 7/29 | Stage 4 | D -33 | 2 of 9 | 0.1 | Conglomerates | – | — | — | Industrials | 6.20 $ | -0.6 % | -10.3 % | -19.8 % | −34.5 % | +41.0 % | 48 | 2 | 6.0 % | 5.0 % | 1.74 | — | 42.4 | 0.2 | — | 3.9 | 0.49 | 6.7 | — | 20.4 % | -3.5 % | -4.7 % | -0.5 % | — | — | -5.1 % | 0.0 % | 0.0 % | 5.9 | 76.7 % | 3.7 % | — |
| UEC Uranium Energy Corp | — | +78 % | 4 0/10 | Stage 4 | D -23 | 2 of 9 | 5.2 | Uranium | – | — | — | Energy | 9.40 $ | -2.9 % | -12.6 % | +65.4 % | −47.9 % | +72.3 % | 46 | 6 | 6.8 % | 8.0 % | 1.19 | — | 178.6 | 259.4 | 3.8 | — | 1.37 | 186.7 | -629.7 % | -396.0 % | 0.0 % | -9.0 % | -6.3 % | — | 92.4 % | +29,738.0 % | 0.0 % | 0.0 % | 16.9 | 84.7 % | 14.1 % | 1.0 (8) |
| BEPC Brookfield Renewable Corp | 08/07 | +12 % | 85 5/15 | Stage 4 | D -35 | 3 of 9 | 6.8 | Utilities - Renewable | – | — | — | Utilities | 34.20 $ | +0.7 % | -3.0 % | +22.1 % | −16.7 % | +9.0 % | 46 | 1 | 3.1 % | 3.1 % | 1.16 | — | 14.6 | 1.7 | 55.3 | — | 2.30 | 38.2 | 14.5 % | 58.4 % | -122.4 % | -47.8 % | 1.1 % | -4.35 | -5.6 % | -10.0 % | 4.3 % | 0.2 % | — | 77.9 % | 1.1 % | 1.4 (7) |
| RGNX Regenxbio Inc | 08/06 | -16 % | 15 2/22 | Stage 4 | D -47 | 1 of 9 | 0.5 | Biotechnology | – | — | — | Healthcare | 10.30 $ | -30.9 % | -18.2 % | +26.8 % | −36.8 % | +137.9 % | 46 | 42 | 13.1 % | 9.4 % | 0.90 | — | 0.0 | 5.9 | — | — | 0.26 | -3.4 | — | -196.6 % | 0.0 % | -196.4 % | -38.5 % | — | — | +104.5 % | 0.0 % | 0.0 % | -10.9 | 84.7 % | 19.3 % | — |
| AMBA Ambarella Inc | 08/27 | -6 % | 61 6/25 | Stage 4 | C +5 | 3 of 9 | 3.0 | Semiconductor Equipment & Ma | – | — | — | Technology | 65.70 $ | -7.5 % | -6.6 % | +22.2 % | −33.7 % | +48.2 % | 45 | 42 | 6.3 % | 7.7 % | 2.11 | — | 112.4 | 7.5 | 4.5 | 115.8 | 4.97 | -57.1 | -19.4 % | 58.8 % | -17.2 % | -11.8 % | -6.4 % | 0.02 | 76.2 % | +37.2 % | 0.0 % | 0.0 % | 6.6 | 87.1 % | 7.9 % | 1.5 (15) |
| MLYS Mineralys Therapeutics, Inc. Commo | 08/11 | -5 % | 55 5/22 | Stage 4 | D -24 | 2 of 9 | 2.3 | Biotechnology | – | — | — | Healthcare | 26.70 $ | -29.4 % | -28.2 % | +87.2 % | −44.7 % | +86.0 % | 45 | 42 | 4.9 % | 5.7 % | 0.65 | — | 0.0 | — | — | — | — | -7.4 | — | — | 0.0 % | -31.0 % | -21.3 % | — | — | — | 0.0 % | 0.0 % | 51.1 | 110.0 % | 11.8 % | — |
| U Unity Software Inc | 08/05 | -9 % | 60 6/25 | Stage 4 | C -8 | 3 of 9 | 11.5 | Software - Application | – | — | — | Technology | 29.80 $ | -37.5 % | -37.7 % | +16.5 % | −48.8 % | +32.1 % | 44 | 42 | 5.1 % | 5.9 % | 2.05 | — | 31.2 | 6.0 | 4.0 | 24.7 | — | 134.6 | -15.2 % | 74.7 % | -35.0 % | -20.1 % | -4.0 % | 0.75 | 45.6 % | +2.0 % | 0.0 % | 0.0 % | 2.7 | 81.9 % | 8.6 % | 1.4 (29) |
| ASMB Assembly Biosciences Inc | 08/05 | +35 % | 70 6/22 | Stage 4 | D -19 | 4 of 9 | 0.5 | Biotechnology | – | — | — | Healthcare | 25.10 $ | -21.2 % | -20.7 % | +49.8 % | −38.9 % | +106.1 % | 43 | 42 | 7.1 % | 6.7 % | 1.08 | 303.3 | 15.7 | 6.8 | 2.4 | — | — | 0.4 | — | 8.8 % | -9.0 % | -5.7 % | -5.1 % | 0.01 | — | +153.5 % | 0.0 % | 0.0 % | 2.6 | 48.4 % | 12.6 % | — |
| ARRY Array Technologies Inc | 08/06 | -21 % | 62 6/25 | Stage 4 | C -8 | 1 of 9 | 1.3 | Solar | – | — | — | Technology | 6.00 $ | -14.3 % | -28.9 % | +4.1 % | −37.1 % | +33.3 % | 41 | 88 | 7.1 % | 7.8 % | 1.81 | — | 9.7 | 1.1 | 5.0 | 21.8 | 0.82 | 71.6 | 2.0 % | 26.1 % | -5.6 % | -22.7 % | 3.9 % | 2.85 | 18.2 % | +40.2 % | 0.0 % | 0.0 % | 4.6 | 140.9 % | 24.2 % | 1.5 (24) |
| SANA Sana Biotechnology Inc | 08/10 | -26 % | — | Stage 4 | E -64 | 2 of 9 | 0.0 | Biotechnology | – | — | — | Healthcare | 3.10 $ | -17.7 % | -23.8 % | +26.2 % | −50.2 % | +162.9 % | 41 | 50 | 7.7 % | 7.0 % | 2.14 | — | 0.0 | — | 7.7 | — | — | -1.1 | — | — | 0.0 % | -147.4 % | -27.5 % | 0.63 | — | — | 0.0 % | 0.0 % | -15.9 | 82.8 % | 26.0 % | — |
| MAZE Maze Therapeutics, Inc. Common Stock | 08/11 | — | — | Stage 4 | E -55 | 3 of 9 | 0.0 | Biotechnology | – | — | — | Healthcare | 28.40 $ | -36.3 % | -31.1 % | +148.6 % | −49.6 % | +131.5 % | 41 | 50 | 5.1 % | 5.1 % | — | — | 8.5 | — | 4.4 | — | — | 6.1 | — | 100.0 % | 0.0 % | -38.7 % | -22.3 % | 0.18 | — | -100.0 % | 0.0 % | 0.0 % | 7.5 | 95.6 % | 8.3 % | — |
| NG NovaGold Resources Inc | — | +19 % | 11 2/23 | Stage 4 | D -42 | 4 of 9 | 2.7 | Gold | – | — | — | Basic Materials | 5.20 $ | -22.5 % | -39.5 % | +52.0 % | −57.3 % | +118.2 % | 40 | 42 | 8.2 % | 6.7 % | 2.15 | — | 4.9 | — | — | — | 1.34 | -40.4 | 0.0 % | — | 0.0 % | -52.0 % | -4.4 % | — | 70.3 % | -100.0 % | 0.0 % | 0.0 % | -2.2 | 79.3 % | 5.6 % | 1.0 (8) |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
Weinstein Stage 4 — downtrend: the price sits below the falling 30-week line, with lower highs and lower lows. Avoid on the long side; more likely short candidates.
All scanners are recalculated daily across the entire stock universe — most recently on 21. July 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 418 stocks pass this scanner's criteria (as of 21. July 2026). The 25 strongest hits are shown.
Global filters: 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); fundamentally healthy names (Piotroski ≥ 5 or Funda Rating ≥ +10) are excluded.
This scanner deliberately hunts for red flags — a hit is a finding, not a recommendation: like a smoke detector that beeps so you look in time. A hit is also not a bankruptcy verdict; most companies save themselves (say, through a capital raise, which dilutes existing shareholders). Portfolio owners use the list as an early-warning system, bargain hunters as an anti-shopping list, experienced traders as a watch list — it is never a buy or short recommendation.
Related scanners
- Altman Z: Distress Zone
- Below the 50- & 200-SMA
- Beneish M-Score
- Downward Momentum
- Going Concern (Distress Proxy)
- Insolvency Radar: Cash Running Low
- Kathy Donnelly: Liquid Movers Down
- Mike Webster: Overextended (Webby RSI)
- Near 52-Week Low
- Pradeep Bonde: $ Breakout Bearish
- Pradeep Bonde: 4% Breakout Bearish
- Qullamaggie: Parabolic (Short-Watch)
- RS Weakness (≤10)
- Stage 4 (Downtrend)
- Stan Weinstein: Stage 4B-
- Thomas Insolvency Candidate
- Weakness Cluster
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.